{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T02:09:55Z","timestamp":1722564595955},"reference-count":25,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2019.10355","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T08:04:04Z","timestamp":1557821044000},"source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of proliferation and migration of melanoma cells by ketoconazole and Ganoderma immunomodulatory proteins"],"prefix":"10.3892","author":[{"given":"Chun\u2011Te","family":"Lu","sequence":"first","affiliation":[{"name":"Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pui\u2011Ying","family":"Leong","sequence":"additional","affiliation":[{"name":"Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting\u2011Yi","family":"Hou","sequence":"additional","affiliation":[{"name":"Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2011Ting","family":"Kang","sequence":"additional","affiliation":[{"name":"Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan\u2011Cheng","family":"Chiang","sequence":"additional","affiliation":[{"name":"Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih\u2011Ting","family":"Hsu","sequence":"additional","affiliation":[{"name":"Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan\u2011De","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory and Biotechnology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiunn\u2011Liang","family":"Ko","sequence":"additional","affiliation":[{"name":"Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2011Ping","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"key20200714090747_b1-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/ijc.30706","article-title":"P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models","volume":"141","author":"Lopez-Barcons","year":"2017","journal-title":"Int J Cancer"},{"key":"key20200714090747_b2-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/bcp.13175","article-title":"Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma","volume":"83","author":"Agarwal","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"key20200714090747_b3-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.juro.2010.02.020","article-title":"A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer","volume":"183","author":"Figg","year":"2010","journal-title":"J Urol"},{"key":"key20200714090747_b4-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"873","DOI":"10.4161\/auto.7.8.15698","article-title":"GMI, an immunomodulatory protein from Ganoderma microsporum, induces autophagy in non-small cell lung cancer cells","volume":"7","author":"Hsin","year":"2011","journal-title":"Autophagy"},{"key":"key20200714090747_b5-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"12014","DOI":"10.1021\/jf103068w","article-title":"GMI, a Ganoderma immunomodulatory protein, down-regulates tumor necrosis factor \u03b1-induced expression of matrix metalloproteinase 9 via NF-\u03baB pathway in human alveolar epithelial A549 cells","volume":"58","author":"Lin","year":"2010","journal-title":"J Agric Food Chem"},{"key":"key20200714090747_b6-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"e0125774","DOI":"10.1371\/journal.pone.0125774","article-title":"Immunomodulatory protein from Ganoderma microsporum induces pro-death autophagy through Akt-mTOR-p70S6K pathway inhibition in multidrug resistant lung cancer cells","volume":"10","author":"Chiu","year":"2015","journal-title":"PLoS One"},{"key":"key20200714090747_b7-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1021\/mp500840z","article-title":"GMI, an immunomodulatory protein from Ganoderma microsporum, potentiates cisplatin-induced apoptosis via autophagy in lung cancer cells","volume":"12","author":"Hsin","year":"2015","journal-title":"Mol Pharm"},{"key":"key20200714090747_b8-ol-0-0-10355","doi-asserted-by":"crossref","first-page":"70422","DOI":"10.18632\/oncotarget.19711","article-title":"GMI ablates cancer stemness and cisplatin resistance in oral carcinomas stem cells through IL-6\/Stat3 signaling inhibition","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"key20200714090747_b9-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2014.09.004","article-title":"AMPK: Positive and negative regulation, and its role in whole-body energy homeostasis","volume":"33","author":"Hardie","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"key20200714090747_b10-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1158\/0008-5472.CAN-14-2645","article-title":"Pancreatic cancer cell migration and metastasis is regulated by chemokine-biased agonism and bioenergetic signaling","volume":"75","author":"Roy","year":"2015","journal-title":"Cancer Res"},{"key":"key20200714090747_b11-ol-0-0-10355","first-page":"5831","article-title":"Ginkgolic acid inhibits the invasiveness of colon cancer cells through AMPK activation","volume":"14","author":"Qiao","year":"2017","journal-title":"Oncol Lett"},{"key":"key20200714090747_b12-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1158\/1078-0432.CCR-16-0870","article-title":"Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma","volume":"23","author":"Kalbasi","year":"2017","journal-title":"Clin Cancer Res"},{"key":"key20200714090747_b13-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","article-title":"CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells","volume":"76","author":"Chang","year":"2016","journal-title":"Cancer Res"},{"key":"key20200714090747_b14-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bcp.2011.11.008","article-title":"Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression","volume":"83","author":"Kim","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"key20200714090747_b15-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/sj.jid.5700827","article-title":"Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft","volume":"127","author":"Gazzaniga","year":"2007","journal-title":"J Invest Dermatol"},{"key":"key20200714090747_b16-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/pros.22940","article-title":"CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR","volume":"75","author":"Mitra","year":"2015","journal-title":"Prostate"},{"key":"key20200714090747_b17-ol-0-0-10355","first-page":"2499","article-title":"Combination of CYP inhibitor with MEK\/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells","volume":"33","author":"Lim","year":"2013","journal-title":"Anticancer Res"},{"key":"key20200714090747_b18-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1016\/j.clinthera.2009.11.012","article-title":"Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: A prospective, multicenter, open-label, randomized, two-way crossover drug-drug interaction study","volume":"2","author":"Venkatakrishnan","year":"2009","journal-title":"Clin Ther 31 Pt"},{"key":"key20200714090747_b19-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1200\/JCO.1994.12.4.683","article-title":"Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer","volume":"12","author":"Sella","year":"1994","journal-title":"J Clin Oncol"},{"key":"key20200714090747_b20-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/cncr.21880","article-title":"Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer","volume":"106","author":"Eklund","year":"2006","journal-title":"Cancer"},{"key":"key20200714090747_b21-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijpharm.2014.06.031","article-title":"Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: Preparation, characterization and antitumor activity","volume":"472","author":"Patel","year":"2014","journal-title":"Int J Pharm"},{"key":"key20200714090747_b22-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1073\/pnas.1007694108","article-title":"AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma","volume":"108","author":"Namiki","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714090747_b23-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1158\/1535-7163.MCT-12-1226-T","article-title":"Metformin blocks melanoma invasion and metastasis development in AMPK\/p53-dependent manner","volume":"12","author":"Cerezo","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"key20200714090747_b24-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1194\/jlr.M500438-JLR200","article-title":"Regulation of AMP-activated protein kinase and acetyl-CoA carboxylase phosphorylation by palmitate in skeletal muscle cells","volume":"47","author":"Fediuc","year":"2006","journal-title":"J Lipid Res"},{"key":"key20200714090747_b25-ol-0-0-10355","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1172\/JCI70645","article-title":"Host immunity contributes to the anti-melanoma activity of BRAF inhibitors","volume":"123","author":"Knight","year":"2013","journal-title":"J Clin Invest"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:52:00Z","timestamp":1594720320000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2019.10355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":25,"URL":"https:\/\/doi.org\/10.3892\/ol.2019.10355","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]}}}